Evaluating the Performance of Malaria Genetics for Inferring Changes in Transmission Intensity Using Transmission Modeling.
genetics
malaria
modeling
surveillance
Journal
Molecular biology and evolution
ISSN: 1537-1719
Titre abrégé: Mol Biol Evol
Pays: United States
ID NLM: 8501455
Informations de publication
Date de publication:
04 01 2021
04 01 2021
Historique:
pubmed:
9
9
2020
medline:
22
6
2021
entrez:
8
9
2020
Statut:
ppublish
Résumé
Substantial progress has been made globally to control malaria, however there is a growing need for innovative new tools to ensure continued progress. One approach is to harness genetic sequencing and accompanying methodological approaches as have been used in the control of other infectious diseases. However, to utilize these methodologies for malaria, we first need to extend the methods to capture the complex interactions between parasites, human and vector hosts, and environment, which all impact the level of genetic diversity and relatedness of malaria parasites. We develop an individual-based transmission model to simulate malaria parasite genetics parameterized using estimated relationships between complexity of infection and age from five regions in Uganda and Kenya. We predict that cotransmission and superinfection contribute equally to within-host parasite genetic diversity at 11.5% PCR prevalence, above which superinfections dominate. Finally, we characterize the predictive power of six metrics of parasite genetics for detecting changes in transmission intensity, before grouping them in an ensemble statistical model. The model predicted malaria prevalence with a mean absolute error of 0.055. Different assumptions about the availability of sample metadata were considered, with the most accurate predictions of malaria prevalence made when the clinical status and age of sampled individuals is known. Parasite genetics may provide a novel surveillance tool for estimating the prevalence of malaria in areas in which prevalence surveys are not feasible. However, the findings presented here reinforce the need for patient metadata to be recorded and made available within all future attempts to use parasite genetics for surveillance.
Identifiants
pubmed: 32898225
pii: 5902837
doi: 10.1093/molbev/msaa225
pmc: PMC7783189
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
274-289Subventions
Organisme : Wellcome Trust
ID : 212176
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 103602
Pays : United Kingdom
Organisme : NIGMS NIH HHS
ID : U54 GM088558
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI089674
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 109312/Z/15/Z
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : K24 AI144048
Pays : United States
Organisme : Wellcome Trust
ID : 105272/Z/14/Z
Pays : United Kingdom
Organisme : World Health Organization
ID : 001
Pays : International
Organisme : Medical Research Council
ID : MR/R015600/1
Pays : United Kingdom
Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Molecular Biology and Evolution.
Références
Nat Commun. 2010 Nov 02;1:108
pubmed: 21045826
Stat Methods Med Res. 1996 Dec;5(4):339-55
pubmed: 9004377
Elife. 2019 Apr 02;8:
pubmed: 30938289
J Am Mosq Control Assoc. 1992 Dec;8(4):404-8
pubmed: 1474388
Lancet Infect Dis. 2016 Apr;16(4):465-72
pubmed: 26809816
Wellcome Open Res. 2017 Feb 14;2:10
pubmed: 28612053
Proc Natl Acad Sci U S A. 2015 Jun 2;112(22):7067-72
pubmed: 25941365
Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):20129-34
pubmed: 24259712
Elife. 2019 Jul 12;8:
pubmed: 31298657
Proc Natl Acad Sci U S A. 2015 Jun 2;112(22):6782-3
pubmed: 26016526
PLoS Pathog. 2007 Mar;3(3):e34
pubmed: 17367208
Science. 2012 Apr 6;336(6077):79-82
pubmed: 22491853
PLoS Med. 2010 Jul 06;7(7):e1000304
pubmed: 20625549
Malar J. 2015 Aug 19;14:321
pubmed: 26283418
Elife. 2019 May 02;8:
pubmed: 31045490
J Infect Dis. 2005 Feb 15;191(4):619-26
pubmed: 15655787
Genome Med. 2017 Jan 24;9(1):5
pubmed: 28118860
PLoS Comput Biol. 2018 Jan 9;14(1):e1005923
pubmed: 29315306
Sci Rep. 2018 May 16;8(1):7713
pubmed: 29769582
Malar J. 2010 Jan 15;9:19
pubmed: 20074380
Nat Commun. 2014;5:3136
pubmed: 24518518
Trends Parasitol. 2007 Feb;23(2):63-70
pubmed: 17188574
Malar J. 2010 Nov 04;9:311
pubmed: 21050427
Malar J. 2015 Dec 30;14:528
pubmed: 26714465
PLoS Comput Biol. 2017 Jan 26;13(1):e1005348
pubmed: 28125584
PLoS One. 2016 Oct 6;11(10):e0164054
pubmed: 27711149
Elife. 2017 Aug 24;6:
pubmed: 28837020
Elife. 2019 Apr 02;8:
pubmed: 30938286
Science. 2004 Jan 16;303(5656):327-32
pubmed: 14726583
J Infect Dis. 2014 Nov 1;210(9):1456-63
pubmed: 24829466
Sci Rep. 2013 Dec 04;3:3418
pubmed: 24301557
PLoS Genet. 2017 Oct 27;13(10):e1007065
pubmed: 29077712
Science. 2012 Nov 2;338(6107):612-4
pubmed: 23118172
PLoS One. 2013 Apr 04;8(4):e60780
pubmed: 23593309
Lancet Glob Health. 2015 Dec;3(12):e758-66
pubmed: 26545449
Int J Parasitol Drugs Drug Resist. 2012 Jul 17;2:191-9
pubmed: 24533280
Cell Microbiol. 2016 Jul;18(7):905-18
pubmed: 27111866
PLoS Comput Biol. 2015 Dec 30;11(12):e1004613
pubmed: 26717515
Nature. 2015 Oct 8;526(7572):207-211
pubmed: 26375008
Cell Host Microbe. 2020 Jan 8;27(1):93-103.e4
pubmed: 31901523
PLoS Med. 2010 Aug 10;7(8):
pubmed: 20711482
Lancet. 2019 Jul 27;394(10195):322-331
pubmed: 31229234
Lancet Infect Dis. 2017 May;17(5):491-497
pubmed: 28161569
Nat Med. 2011 Jun;17(6):732-7
pubmed: 21572427
Genetics. 2009 Dec;183(4):1421-30
pubmed: 19797047
Evolution. 2001 Jul;55(7):1299-307
pubmed: 11525454
Mol Ecol. 2013 Jan;22(2):273-85
pubmed: 23121253
Am J Trop Med Hyg. 2013 Nov;89(5):850-6
pubmed: 24019439
Nat Commun. 2012 Jun 06;3:881
pubmed: 22673908
Science. 2000 Feb 4;287(5454):845-8
pubmed: 10657296
Elife. 2013 May 21;2:e00626
pubmed: 23705071
J R Soc Interface. 2016 Apr;13(117):
pubmed: 27075004
Malar J. 2016 Jan 11;15:20
pubmed: 26754795
Wellcome Open Res. 2017 Sep 5;2:29
pubmed: 28944299